Allspring Global Investments
SRNE

Allspring Global Investments’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Allspring Global Investments’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45,632
Closed -$40.4K – 3003
2022
Q4 		$40.4K Sell
45,632
-998
-2% -$1.32K ﹤0.01% 2394
2022
Q3 		$73K Buy
46,630
+46,624
+777,067% +$106K ﹤0.01% 2207
2022
Q2 		$0 Sell
6
-186,331
-100% -$322K ﹤0.01% 3040
2022
Q1 		$434K Sell
186,337
-15,955
-8% -$49.8K ﹤0.01% 2279
2021
Q4 		$940K Buy
+202,292
New +$1.26M ﹤0.01% 1984

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Allspring Global Investments's SRNE Position: Q1 2023 in Review

Allspring Global Investments sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 45,632 shares — an estimated $40.4K sold.

Allspring Global Investments first reported a position in SRNE in Q4 2021 and held it in 5 quarters. The position peaked at $940K in Q4 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Allspring Global Investments reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Allspring Global Investments sold 45,632 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $40.4K.
  • Allspring Global Investments first reported a position in Sorrento Therapeutics, Inc. in Q4 2021 and held it in 5 quarters.
  • Allspring Global Investments's Sorrento Therapeutics, Inc. position peaked at $940K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Allspring Global Investments's 13F filing for Q1 2023, filed 13 Apr 2023.